外科理论与实践

外科理论与实践 >

2025 , Vol. 30 >Issue 06: 479 - 482

DOI: https://doi.org/10.16139/j.1007-9610.2025.06.04

专家论坛

人工智能在胰腺癌术前诊断中的应用进展

  • 毛谅 ,
  • 仇毓东
展开
  • 南京大学医学院附属鼓楼医院 胰腺与代谢外科， 江苏 南京 210008
仇毓东，E-mail: yudongqiu510@163.com

收稿日期: 2025-06-19

  网络出版日期: 2026-01-26

收起

Application progress of artificial intelligence in preoperative diagnosis of pancreatic cancer

  • MAO Liang ,
  • QIU Yudong
Expand
  • Department of Pancreatic and Metabolic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical School, Jiangsu Nanjing 210008, China

Received date: 2025-06-19

  Online published: 2026-01-26

Fold

摘要

胰腺癌是胰腺外科领域最严峻的挑战，准确的术前诊断是改善预后的关键。目前，人工智能（AI）在胰腺癌早期诊断、鉴别诊断和分层诊断中的应用均有研究报道。本文概述其中的代表性研究，并重点介绍其创新思维、建模方法、研究结果和临床意义，展示AI在胰腺癌术前诊断中的应用潜力，以期对该领域的后续研究有所启示。

关键词： 人工智能; 胰腺癌; 早期诊断; 分层诊断; 超声造影; 超声内镜; 快速现场病理

本文引用格式

毛谅 , 仇毓东 . 人工智能在胰腺癌术前诊断中的应用进展[J]. 外科理论与实践, 2025 , 30(06) : 479 -482 . DOI: 10.16139/j.1007-9610.2025.06.04

Abstract

Pancreatic cancer is the most challenging issue in the field of pancreatic surgery. Accurate preoperative diagnosis is the key to improving prognosis. Currently, there have been research reports on the application of artificial intelligence(AI) in the early diagnosis, differential diagnosis, and stratified diagnosis of pancreatic cancer. This article summarized the representative studies and focused on introducing their innovative thinking, modeling methods, research results, and clinical significance, demonstrating the application potential of AI in preoperative diagnosis of pancreatic cancer, with the aim of providing inspiration for subsequent research in this field.

Key words： Artificial intelligence (AI); Pancreatic cancer; Early diagnosis; Stratified diagnosis; Contrast-enhanced ultrasound; Ultrasonic endoscope (EUS); Rapid on-site evaluation (ROSE)

参考文献

[1] HAN B, ZHENG R, ZENG H, et al. Cancer incidence and mortality in China, 2022[J]. J Natl Cancer Cent, 2024, 4(1):47-53.
[2] SIEGEL R L, KRATZER T B, GIAQUINTO A N, et al. Cancer statistics, 2025[J]. CA Cancer J Clin, 2025, 75(1):10-45.
[3] STOOP T F, JAVED A A, OBA A, et al. Pancreatic cancer[J]. Lancet, 2025, 405(10485):1182-1202.
[4] WOOD L D, CANTO M I, JAFFEE E M, et al. Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment[J]. Gastroenterology, 2022, 163(2):386-402.
[5] MUKHERJEE S, PATRA A, KHASAWNEH H, et al. Radiomics-based machine-learning models can detect pancreatic cancer on prediagnostic computed tomography scans at a substantial lead time before clinical diagnosis[J]. Gastroenterology, 2022, 163(5):1435-1446.
[6] SIJITHRA P C, SANTHI N, RAMASAMY N. A review study on early detection of pancreatic ductal adenocarcinoma using artificial intelligence assisted diagnostic methods[J]. Eur J Radiol, 2023, 166:110972.
[7] CAO K, XIA Y, YAO J, et al. Large-scale pancreatic cancer detection via non-contrast CT and deep learning[J]. Nat Med, 2023, 29(12):3033-3043.
[8] TONG T, GU J, XU D, et al. Deep learning radiomics based on contrast-enhanced ultrasound images for assisted diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis[J]. BMC Med, 2022, 20(1):74.
[9] LI X Z, SONG J, SUN Z X, et al. Diagnostic performance of contrast-enhanced ultrasound for pancreatic neoplasms: a systematic review and meta-analysis[J]. Dig Liver Dis, 2018, 50(2):132-138.
[10] KUWAHARA T, HARA K, MIZUNO N, et al. Artificial intelligence using deep learning analysis of endoscopic ultrasonography images for the differential diagnosis of pancreatic masses[J]. Endoscopy, 2023, 55(2):140-149.
[11] ZHANG S, ZHOU Y, TANG D, et al. A deep learning-based segmentation system for rapid onsite cytologic pathology evaluation of pancreatic masses: a retrospective, multicenter, diagnostic study[J]. EBioMedicine, 2022, 80:104022.
[12] CHU L C, FISHMAN E K. Pancreatic ductal adenocarcinoma staging: a narrative review of radiologic techniques and advances[J]. Int J Surg, 2024, 110(10):6052-6063.
[13] YAO J, CAO K, HOU Y, et al. Deep learning for fully automated prediction of overall survival in patients undergoing resection for pancreatic cancer: a retrospective multicenter study[J]. Ann Surg, 2023, 278(1):e68-e79.
[14] MIZRAHI J D, SURANA R, VALLE J W, et al. Pancreatic cancer[J]. Lancet, 2020, 395(10242):2008-2020.
[15] PRYCE B R, WANG D J, ZIMMERS T A, et al. Cancer cachexia: involvement of an expanding macroenvironment[J]. Cancer Cell, 2023, 41(3):581-584.
[16] LáINEZ RAMOS-BOSSINI A J, GáMEZ MARTíNEZ A, LUENGO GóMEZ D, et al. Computed tomography-based sarcopenia and pancreatic cancer survival-a comprehensive meta-analysis exploring the influence of definition criteria, prevalence, and treatment intention[J]. Cancers (Basel), 2025, 17(4):607.
[17] BEDRIKOVETSKI S, SEOW W, KROON H M, et al. Artificial intelligence for body composition and sarcopenia evaluation on computed tomography: a systematic review and meta-analysis[J]. Eur J Radiol, 2022, 149:110218.
[18] SGUANCI M, PALOMARES S M, CANGELOSI G, et al. Artificial intelligence in the management of malnutrition in cancer patients: a systematic review[J]. Adv Nutr, 2025, 16(7):100438.
[19] PORCIELLO G, DI LAURO T, LUONGO A, et al. Optimizing nutritional care with machine learning: identifying sarcopenia risk through body composition parameters in cancer patients-insights from the nutritional and sarcopenia risk screening project (NUTRISCREEN)[J]. Nutrients, 2025, 17(8):1376.
[20] MUKUND A, AFRIDI M A, KAROLAK A, et al. Pancreatic ductal adenocarcinoma (PDAC): a review of recent advancements enabled by artificial intelligence[J]. Cancers (Basel), 2024, 16(12):2240.
Options
文章导航

/

〈 〉